STOCK TITAN

iCAD to Participate at the Imagine AI + Healthcare Investor Summit

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
conferences AI

Rhea-AI Summary

NASHUA, N.H., Dec. 6, 2021 -- iCAD, a leader in cancer detection and therapy solutions, announced that Stacey Stevens, President and incoming CEO, will present at Oppenheimer’s Imagine AI + Healthcare Investor Summit. The presentation is scheduled for December 7, 2021, from 11:00 a.m. to 11:20 a.m. ET. This event, organized by Oppenheimer in collaboration with the Alliance for AI in Healthcare, highlights advancements in AI technology within healthcare.

For more information, visit www.icadmed.com.

Loading...
Loading translation...
Argus Session date unavailable
-4.96% session move Open Argus
Details

News Market Reaction – ICAD

The recorded move for ICAD in the trading session of this news was -4.96%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

NASHUA, N.H., Dec. 06, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Stacey Stevens, President and incoming Chief Executive Officer, will present a corporate overview at Oppenheimer’s Imagine AI + Healthcare Investor Summit being hosted by Oppenheimer in partnership with the Alliance for AI in Healthcare (AAIH).

Oppenheimer’s Imagine AI + Healthcare Investor Summit
Date:        Tuesday, December 7th
Time:        11:00 a.m. to 11:20 a.m. ET
Registration Link

About iCAD, Inc.
Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com.

Contact:
Media Inquiries:
Jessica Burns, iCAD
+1-201-423-4492
jburns@icadmed.com

Investor Relations:
Brian Ritchie, LifeSci Advisors
+ 1-212-915-2578
britchie@lifesciadvisors.com


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is iCAD's presentation time at Oppenheimer’s Imagine AI + Healthcare Investor Summit?

iCAD's presentation is scheduled for December 7, 2021, from 11:00 a.m. to 11:20 a.m. ET.

Who is presenting at the Oppenheimer Investor Summit for iCAD?

Stacey Stevens, the President and incoming CEO, will present on behalf of iCAD.

What is Oppenheimer’s Imagine AI + Healthcare Investor Summit about?

The summit focuses on AI advancements in healthcare, showcasing innovative solutions and technologies.

Where is iCAD located?

iCAD is headquartered in Nashua, New Hampshire.

What does iCAD specialize in?

iCAD specializes in innovative cancer detection and therapy solutions.

Keep reading